Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | YAP1 | P46937 | 3/20 | 0.56 |
| ▸ | GPR119 | Q8TDV5 | 11/20 | 0.55 |
| ▸ | PRMT5 | O14744 | 4/20 | 0.53 |
| ▸ | STS | P08842 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8475560 | 0.87 | GPR119 (0.67) | YAP1GPR119PRMT5STS | |
| SCHEMBL8475556 | 0.87 | GPR119 (0.67) | YAP1GPR119PRMT5STS | |
| SCHEMBL12813454 | 0.86 | YAP1 (0.66) | YAP1GPR119PRMT5STS | |
| SCHEMBL7363874 | 0.85 | GPR119 (0.58) | GPR119 | |
| SCHEMBL21996804 | 0.84 | GPR119 (0.57) | YAP1GPR119STS | |
| SCHEMBL12526668 | 0.84 | GPR119 (0.57) | YAP1GPR119STS | |
| SCHEMBL7364852 | 0.84 | GPR119 (0.51) | GPR119 | |
| SCHEMBL2883449 | 0.84 | GPR119 (0.58) | YAP1GPR119PRMT5 | |
| SCHEMBL31753740 | 0.82 | GPR119 (0.59) | GPR119 | |
| SCHEMBL76105 | 0.82 | YAP1 (0.60) | YAP1GPR119PRMT5STS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5994356-A | ANTICOAGULANT | KARL THOMAE (DE) | 1999-11-30 | — | — | US | disclosed |
| EP-0892783-A1 | CARBOXYLIC ACID DERIVATIVES WITH AN AGGREGATION-INHIBITING ACTION | Dr. Karl Thomae GmbH (DE) | 1999-01-27 | — | — | EP | disclosed |
| WO-1997037975-A1 | CARBOXYLIC ACID DERIVATIVES WITH AN AGGREGATION-INHIBITING ACTION | DR. KARL THOMAE GMBH (DE) | 1997-10-16 | — | — | WO | disclosed |